Finance

Lists
GOVX:NASDAQ
Geovax Labs Inc
0,28 $
-1,95%
(-0,0056) 1D
0,28 $
-0,04% (-0,000100)
After hours
Closed: 9 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GOVX...
Open
0,28 $
High
0,30 $
Low
0,27 $
Mkt. cap
2,53 մլն
Avg. vol.
870,99 հզր
Volume
235,10 հզր
52-wk high
15,75 $
52-wk low
0,27 $
EPS
-13,92 $
Beta
3,69
Shares outstanding
10,10 մլն
No. of employees
19
Open
0,28 $
High
0,30 $
Low
0,27 $
Mkt. cap
2,53 մլն
Avg. vol.
870,99 հզր
Volume
235,10 հզր
52-wk high
15,75 $
52-wk low
0,27 $
EPS
-13,92 $
Beta
3,69
Shares outstanding
10,10 մլն
No. of employees
19
News stories
From web sources and news partners
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersԱտլանտա, Ջորջիա, Միացյալ Նահանգներ
Sector-
Websitegeovax.com
Analyst ratings
Based on 1 analyst giving stock ratings to GOVX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GOVX in the last 3 months
Highest
Current 0,28 $
10,00 $ (+3 458,72%)
Average
10,00 $ (+3 458,72%)
Lowest
10,00 $ (+3 458,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
10,00 $
+3 458,7%
09/17/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
10,00 $
+3 458,7%
05/26/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
5,04 մլն
2,99 մլն
3,90 մլն
3,11 մլն
Cost of revenue
5,04 մլն
2,99 մլն
3,90 մլն
3,11 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,33 մլն
1,45 մլն
1,37 մլն
1,33 մլն
Operating expense
1,33 մլն
1,45 մլն
1,37 մլն
1,33 մլն
Total operating expenses
6,37 մլն
4,44 մլն
5,27 մլն
4,44 մլն
Operating income
-6,37 մլն
-4,44 մլն
-5,27 մլն
-4,44 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-6,32 մլն
-4,42 մլն
-5,26 մլն
-4,43 մլն
EBT excluding unusual items
-6,32 մլն
-4,42 մլն
-5,26 մլն
-4,43 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6,32 մլն
-4,42 մլն
-5,26 մլն
-4,43 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
54,30 հզր
23,33 հզր
10,96 հզր
15,49 հզր
Interest expense
-
-
-
-
Net interest expenses
54,30 հզր
23,33 հզր
10,96 հզր
15,49 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,36 մլն
-4,42 մլն
-5,26 մլն
-4,43 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps